Journal article
Oral omega-3 supplementation lowers intraocular pressure in normotensive adults
LE Downie, AJ Vingrys
Translational Vision Science and Technology | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | Published : 2018
DOI: 10.1167/tvst.7.3.1
Abstract
Purpose: Elevated intraocular pressure (IOP) is the major modifiable risk factor for the sight-threatening eye disease, glaucoma. We investigated whether oral omega-3 supplements affect IOP in normotensive adults. Methods: We undertook a pooled analysis of data from two double-masked, placebo-controlled randomized trials (Australian New Zealand Clinical Trials Registry, ACTRN12614001019695, ACTRN12615000173594) that investigated the efficacy and safety of oral omega-3 supplementation for treating ocular surface inflammation. Recruitment involved adults (n = 105) with IOP <21 mm Hg, and without a current or prior glaucoma diagnosis. Participants were randomly allocated to either an oral omega..
View full abstractRelated Projects (2)
Grants
Funding Acknowledgements
The dry eye clinical trial was funded by a University of Melbourne Early Career Researcher Grant (LED) and the contact lens discomfort clinical trial was funded by CooperVision Pty Ltd (LED). The authors report no conflicts of interest in relation to this submission.